Autoinhibition of IL-15 expression in KC cells is ERK1/2 and PI3K dependent

Scandinavian Journal of Immunology

Volumn 68, Issue 4, 2008, Pages 397-404

  Zhang, S Q ^a   Luo, X ^a   Yang, S ^a   Liu, J L ^a   Yang, C J ^a   Yin, X Y ^a   Huang, H L ^a   Zhang, X J ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 15; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCLONAL ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AUTOREGULATION; CELL CULTURE; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; TRANSCRIPTION REGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-15; INTERLEUKIN-6; KERATINOCYTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 51349103930     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2008.02150.x     Document Type: Article

References (34)

1. Grabstein KH, Eisenman J, Shanebeck K et al. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 1994 264 : 965 8.
2. Meazza R, Verdiani S, Biassoni R et al. Identification of a novel interleukin-15 (IL-15) transcript isoform generated by alternative splicing in human small cell lung cancer cell lines. Oncogene 1996 12 : 2187 223.
3. Onu A, Pohl T, Krause H, Bulfone-Paus S. Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms. J Immunol 1997 158 : 255 62.
4. Tagaya Y, Kurys G, Thies TA et al. Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides. Proc Natl Acad Sci U S A 1997 94 : 14444 9.
5. Waldmann TA, Tagaya Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol 1999 17 : 19 49.
6. Fehniger TA, Caligiuri MA. Interleukin 15: biology and relevance to human disease. Blood 2001 97 : 14 32.
7. Koka R, Burkett PR, Chien M et al. Interleukin (IL)-15R[alpha]-deficient natural killer cells survive in normal but not IL-15R[alpha]-deficient mice. J Exp Med 2003 197 : 977 84.
8. Burkett PR, Koka R, Chien M et al. IL-15R alpha expression on CD8+ T cells is dispensable for T cell memory. Proc Natl Acad Sci U S A 2003 100 : 4724 9.
9. +T cells. Proc Natl Acad Sci U S A 2006 103 : 12075 80.
10. Marks-Konczalik J, Dubois S, Losi JM et al. IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. Proc Natl Acad Sci U S A 2000 97 : 11445 50.
11. Rückert R, Asadullah K, Seifert M et al. Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis? J Immunol 2000 165 : 2240 50.
12. McDonald PP, Russo MP, Ferrini S, Cassatella MA. Interleukin-15 (IL-15) induces NF-kappaB activation and IL-8 production in human neutrophils. Blood 1998 92 : 4828 35.
13. Tagaya Y, Bamford RN, DeFilippis AP, Waldmann TA. IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 1996 4 : 329 36.
14. Masuda A, Matsuguchi T, Yamaki K et al. Interleukin-15 induces rapid tyrosine-phosphorylation of STAT6 and the expression of interleukin-4 in mouse mast cells. J Biol Chem 2000 275 : 29331 7.
15. Yano S, Komine M, Fujimoto M, Okochi H, Tamaki K. Interleukin 15 induces the signals of epidermal proliferation through ERK and PI 3-kinase in a human epidermal keratinocyte cell line, HaCaT. Biochem Biophys Res Commun 2003 301 : 841 7.
16. Zhang XJ, Yan KL, Wang ZM et al. Polymorphisms in interleukin-15 gene on chromosome 4q31.2 are associated with psoriasis vulgaris in Chinese population. J Invest Dermatol 2007 127 : 2544 51.
17. Bernard J, Harb C, Mortier E et al. Identification of an interleukin-15 receptor-binding site on human interleukin-15. J Biol Chem 2004 279 : 24313 22.
18. Nishimura H, Fujimoto A, Tamura N, Yajima T, Wajjwalku W, Yoshikai Y. A novel autoregulatory mechanism for transcriptional activation of the IL-15 gene by a nonsecretable isoform of IL-15 generated by alternative splicing. FASEB J 2005 19 : 19 28.
19. Kishimoto T. The biology of interleukin-6. Blood 1989 74 : 1 10.
20. Okamoto M, Lee C, Oyasu R. Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro. Cancer Res 1997 57 : 141 6.
21. Xiao W, Hodge DR, Wang L, Yang X, Zhang X, Farrar WL. Co-operative functions between nuclear factors NFκB and CCAT/enhancer-binding protein- (C/EBP-) regulate the IL-6 promoter in autocrine human prostate cancer cells. Prostate 2004 61 : 354 70.
22. Xiao W, Hodge DR, Wang L, Yang X, Zhang X, Farrar WL. NF-κB activates IL-6 expression through cooperation with c-Jun and IL6-AP1 site, but is independent of its IL6-NFκB regulatory site in autocrine human multiple myeloma cells. Cancer Biol Ther 2004 3 : 1007 17.
23. 1 fibronectin receptor. J Urol 2000 163 : 1553 9.
24. Helfgott DC, May LT, Sthoeger Z, Tamm I, Sehgal PB. Bacterial lipopolysaccharide (endotoxin) enhances expression and secretion of beta 2 interferon by human fibroblasts. J Exp Med 1987 166 : 1300 9.
25. Alleva DG, Kaser SB, Monroy MA, Fenton MJ, Beller DI. IL-15 functions as a potent autocrine regulator of macrophage proinflammatory cytokine production: evidence for differential receptor subunit utilization associated with stimulation or inhibition. J Immunol 1997 159 : 2941 51.
26. Strange P, Cooper KD, Hansen ER et al. T-lymphocyte clones initiated from lesional psoriatic skin release growth factors that induce keratinocyte proliferation. J Invest Dermatol 1993 101 : 695 700.
27. Gottlieb SL, Gilleaudeau P, Johnson R et al. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat Med 1995 1 : 442 7.
28. Gilhar A, Ullmann Y, Kerner H et al. Psoriasis is mediated by a cutaneous defect triggered by activated immunocytes: induction of psoriasis by cells with natural killer receptors. J Invest Dermatol 2002 119 : 384 91.
29. Nickoloff BJ, Bonish B, Huang BB, Porcelli SA. Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system. J Dermatol Sci 2000 24 : 212 25.
30. Ettehadi P, Greaves MW, Wallach D, Aderka D, Camp RD. Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions. Clin Exp Immunol 1994 96 : 146 51.
31. Chaudhari U, Romano P, Mulcahy LD, Dooley LT, Baker DG, Gottlieb AB. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial. Lancet 2001 357 : 1842 7.
32. Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet 2000 356 : 385 90.
33. Nickoloff BJ. Characterization of lymphocyte-dependent angiogenesis using a SCID mouse: human skin model of psoriasis. J Investig Dermatol Symp Proc 2000 5 : 67 73.
34. Ong PY, Hamid QA, Travers JB et al. Decreased IL-15 may contribute to elevated IgE and acute inflammation in atopic dermatitis. J Immunol 2002 168 : 505 10.